PRESS RELEASE published on 01/17/2024 at 08:00, 1 year 2 months ago Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Published on 04/03/2025 at 01:35, 2 hours 34 minutes ago GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 4 hours 34 minutes ago Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 8 hours 9 minutes ago Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 15:00, 13 hours 9 minutes ago Doubleview Gold Corp 2025 Exploration Program
Published on 04/02/2025 at 20:20, 7 hours 49 minutes ago EQS-Adhoc: Siemens Aktiengesellschaft: Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences
Published on 04/02/2025 at 20:01, 8 hours 8 minutes ago Annual General Meeting of Deutsche Konsum REIT-AG successfully held
Published on 04/02/2025 at 20:01, 8 hours 8 minutes ago Travis Perkins: Publication of the Annual Report and Accounts 2024
Published on 04/02/2025 at 19:40, 8 hours 29 minutes ago LION E-Mobility AG starts successfully into the new 2025 financial year – Challenging market environment impacts 2024
Published on 04/02/2025 at 19:13, 8 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/03/2025 at 00:37, 3 hours 32 minutes ago Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Published on 04/03/2025 at 00:37, 3 hours 32 minutes ago Mise à disposition du rapport sur les paiements faits aux gouvernements prévu à l’article L.225-102-3 du Code de commerce
Published on 04/02/2025 at 17:45, 10 hours 24 minutes ago Aéroports de Paris SA - Droits de vote au 31 mars 2025
Published on 04/02/2025 at 17:45, 10 hours 24 minutes ago Aéroports de Paris SA - Voting rights as of 31 March 2025